In other Birth Cohort from the city of Pelotas (The 1982 Cohort), a Mendelian randomization study on the causal effect of adiponectin and cardiovascular risk has been undertaken and the authors found no consistent evidence that genetic predisposition to elevated blood adiponectin levels was associated to reduced risk of cardiovascular disease [53]. Here, ADIPOQ is linked to cardiovascular disorder.